StockDriftsStockDriftsRECURSION PHARMACEUTICALS, INC. has 2 SEC filings in the last 90 days, latest: CEO and President Najat Khan sells $78.8K in stock (4, September 10, 2026). Each filing below is summarised from the document itself and links straight to the original on SEC EDGAR.
Of the 2 filings tracked here, 2 report insider sales. See only RXRX Form 4 filings.
Najat Khan, CEO and President, sold 22,408 shares of stock worth $78,822.38 under a 10b5-1 plan.
Director Blake Borgeson sold 30,000 shares of common stock for a total of $100,200.